Approximately 48% of patients that have been diagnosed with diabetes don’t know they also have associated neuropathy.(1) Will you be able to educate them? Do your lower extremity protocols meet the Clinical Practice Guidelines recommendations for diabetes?
Arche Healthcare, a population health management company (PHM) has established a new paradyam for the care and prevention of diabetic lower extremity complications; educating patients and providing practices with automated processes and protocols for documentation and fulfillment
Arche Healthcare has architected two encompassing, cost-effective healthcare delivery tools that span both sides of a diabetic patients’ health management:
One, the Arche LEAP Alliance®, establishes an alliance of podiatric practices to provide healthcare personnel with efficient tools for Comprehensive Diabetic foot Exams and systems to educate while managing the care and treatment of the diabetic patient’s feet. The lead component of the LEAP Alliance is the ArcheOPTYX system of document processing and patient stratifying and tracking. The metrics established through the ArcheOPTYX system provide the analytic information for the other, CLUE® (Close Losses Upon Examination).
CLUE endows health plan companies with the data and analytics to establish a strategic approach to determine effective allocation of resources with which to equip and support physicians and patients.
Both integrate to set the Standards of Care for Lower Extremity Amputation Prevention (LEAP).
Arche’s coordinated multidisciplinary clinical care platforms are committed to improving clinical outcomes for diabetes populations. Built on unique strategic alliances, the Arche strategies provide a cost-effective healthcare delivery platform to assist in reducing diabetic foot complications.
Created by a team of world renowned clinicians and diabetes researchers, Arche’s programs are evidence-based in practice and endorsed by every diabetes related Clinical Practice Guideline.
Our PHM programs help forward-thinking healthcare providers, health plans and other healthcare stakeholders achieve a compelling ROI given the current expense/outcomes resulting from diabetic foot complications while at the same time, help these healthcare providers meet the new HEDIS requirement on chronic conditions and avoidable hospitalization measures.